Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02128776 · ClinicalTrials.gov registry record · NA
An Enhanced Medical Home for High-Risk Chronically Ill Children
A NA study of Chronic Illnesses, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 1
- Study location
NCT02128776: Completed NA study of Chronic Illnesses, sponsored by The University of Texas Health Science Center, Houston.
NCT02128776 is a NA study of Chronic Illnesses that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02128776, a NA study of Chronic Illnesses, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess whether an enhanced medical home providing comprehensive care is cost-effective in preventing serious illness (death, pediatric intensive care admission, or hospital stay \>7d) among high-risk chronically ill children.
Primary Outcome
Cost per prevented child with serious illness
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Comprehensive care medical home
Study Locations (1)
Texas
- University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT02128776 record still lists
NCT02128776 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Chronic Illnesses appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT02128776 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02128776 about?
NCT02128776 is a clinical study titled "An Enhanced Medical Home for High-Risk Chronically Ill Children". The purpose of this study is to assess whether an enhanced medical home providing comprehensive care is cost-effective in preventing serious illness (death, pediatric intensive care admission, or hospital stay \>7d) among high-risk chronically ill children.
What is the current status of trial NCT02128776?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2011-03. Estimated completion is 2013-08.
What conditions does trial NCT02128776 study?
This clinical trial studies the following conditions: Chronic Illnesses.
What interventions are being tested in trial NCT02128776?
The interventions under investigation include: Usual Care (OTHER), Comprehensive care medical home (OTHER).
Who is sponsoring clinical trial NCT02128776?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02128776 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Illnesses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02128776's enrollment target sits among peer trials
201 506th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia